Press Releases

Pronalyse Anounces PEGylated Protein Identification Methods for Drug Discovery

Alfa Chemistry Released Four Types of Featured Products for the Research Community

In an effort to combine what the customers truly need and what the company provides, Alfa Chemistry recently sorted and released four types of featured products for scientists and researchers who are engaged with the tumor, coronavirus, and flu treatment research as well as the production of personal daily care products.

Applied Photophysics celebrates 50 years

Applied Photophysics, a leading provider of solutions for biophysical characterization of biomolecules, celebrates 50 years in the biopharmaceutical industry.

MicrobioSeq Division Releases Microbial Single-Cell Genome Sequencing to Reveal Heterogeneity of Microbial Populations

Microarray Data Analysis Methods Are Now Available at Bioinformatics-Analysis Division of CD Genomics

GutFlora Omics Platform Releases Total RNA Sequencing Service

Alfa Chemistry Launches a New Sub-Website for the Supply of Graphene and Related CRO Service

Currently graphene has been widely used in modern technology. In order to make graphene products and related CRO services more accessible to scientists and researchers worldwide, Alfa Chemistry announces to have established a new sub-website earlier this month in 2021.

COVID-19 driving manufacturing and CDMOs driving growth per executive survey

Lifeasible Offers a Wide Scope of Feed Testing Services to Ensure Feed Safety and Quality

Profacgen Announced the Release of Protein Lyophilization Service to Assist Protein Research

Isohelix and AutoGen sign a collaborative supply agreement

Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation, have signed a far-reaching supply agreement.

CytoSMART redefines automated cell counting with a new fluorescence cell counter

Today CytoSMART Technologies has announced the release of its first fluorescence cell counter, CytoSMART Exact FL

MedAI Launches Integrated Drug Discovery Approaches to Solve In Silico Drug Discovery Problems

MedAI announces that it has launched integrated drug discovery approaches to help to solve in silico drug discovery challenges, such as problems arising from drug candidate compound screening, target profiling, compound structure scoring in de novo design, and other related calculations.

Formulationbio Provides Comprehensive Formulation Development and Analytical Services for the pharmaceutical Industry

Fully aware of the challenges that may arise from this process, Formulationbio recently announces that it now provides a comprehensive range of formulation development and analytical services for the pharmaceutical industry.

Main Products Provided at Alfa Chemistry Materials: In-Stock and Cost-Effective

For the convenience of customers, Alfa Chemistry Materials recently has sorted out seven categories of products as its main featured products, which can be easily found at the website.

Matexcel Offers a Wide Selection of Hydroxyapatite Products for Research Use

BioIVT Supports In Vitro Diagnostic Device Manufacturers Seeking to Meet New European Market Regulatory Requirements

The IVDR ((EU) 2017/746) provides new definitions of an IVD and changes how they are classified, monitored, and regulated with the intention of improving the quality, safety, and reliability of IVDs. Under the new regulations most IVDs will require certification via a notified body. In many cases, this will require sponsoring manufacturers to conduct associated testing and analytics with specimens from clinical collections and/or clinical trials.

NDA Group announces Christine Lind as the new VP of Commercial

NDA Group, a world-leading regulatory, drug development and medical device consultancy, has appointed Christine Lind as the new VP of Commercial.

Sygnature Discovery expands US presence with office in Bay Area biotech hub

Sygnature Discovery, a world-leading integrated drug discovery and non-clinical solutions provider, has expanded its US presence with a new office in South San Francisco’s biotech hub at Oyster Point.

GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent

GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly $7M (US) in NIH grant awards has led to a seminal US patent for its novel technology.